BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11535538)

  • 21. Risk of second cancer after chronic lymphocytic leukemia.
    Schöllkopf C; Rosendahl D; Rostgaard K; Pipper C; Hjalgrim H
    Int J Cancer; 2007 Jul; 121(1):151-6. PubMed ID: 17351903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic lymphocytic leukemia and loss of strength in the right arm--not a typical combination].
    Sendi P; Puric E; Schönenberger A; Bargetzi M
    Praxis (Bern 1994); 2007 May; 96(18):729-32. PubMed ID: 17520841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
    Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
    Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019.
    van der Straten L; Levin MD; Dinnessen MAW; Visser O; Posthuma EFM; Doorduijn JK; Langerak AW; Kater AP; Dinmohamed AG
    Blood Cancer J; 2023 Jan; 13(1):15. PubMed ID: 36635262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival.
    Ishdorj G; Beiggi S; Nugent Z; Streu E; Banerji V; Dhaliwal D; Mahmud SM; Marshall AJ; Gibson SB; Wiseman MC; Johnston JB
    Leuk Lymphoma; 2019 Dec; 60(13):3204-3213. PubMed ID: 31237469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
    Metayer C; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; Joensuu T; van Leeuwen FE; van't Veer MB; Curtis RE; Holowaty EJ; Andersson M; Wiklund T; Gospodarowicz M; Travis LB
    J Clin Oncol; 2000 Jun; 18(12):2435-43. PubMed ID: 10856104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
    Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Second Primary Cancer Risk Among Chronic Lymphocytic Leukemia Patients: Multicenter Study.
    Sayin S; Kiliacslan E; Yildirim M; Afacan Ozturk HB; Safak Yilmaz E; Albayrak M; Kaptan MK; Ayli M
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):1971-1977. PubMed ID: 37378926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome.
    Biggar RJ; Curtis RE; Cote TR; Rabkin CS; Melbye M
    Am J Epidemiol; 1994 Feb; 139(4):362-8. PubMed ID: 8109570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P
    Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
    Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
    J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravascular Colonization of Kaposi Sarcoma: Expanding the Spectrum of Specific Infiltrates of B-Cell Chronic Lymphocytic Leukemia.
    Saggini A; Del Poeta G; Santinelli E; Bianchi L; Caposiena Caro RD; Orlandi A
    Am J Dermatopathol; 2019 Dec; 41(12):940-944. PubMed ID: 31268930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer.
    Landgren O; Pfeiffer RM; Stewart L; Gridley G; Mellemkjaer L; Hemminki K; Goldin LR; Travis LB
    Int J Cancer; 2007 Mar; 120(5):1099-102. PubMed ID: 17131330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study.
    Solomon BM; Rabe KG; Slager SL; Brewer JD; Cerhan JR; Shanafelt TD
    J Clin Oncol; 2013 Mar; 31(7):930-7. PubMed ID: 23341508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia.
    Herishanu Y; Polliack A; Shenhar-Tsarfaty S; Weinberger R; Gelman R; Ziv-Baran T; Zeltser D; Shapira I; Berliner S; Rogowski O
    Ann Med; 2017 Feb; 49(1):75-82. PubMed ID: 27595291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage I lung cancer survivorship: risk of second malignancies and need for individualized care plan.
    Surapaneni R; Singh P; Rajagopalan K; Hageboutros A
    J Thorac Oncol; 2012 Aug; 7(8):1252-6. PubMed ID: 22627646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.